Clione Biotechnologies Solving Global Challenges by leveraging Biotechnology

Cover image of Clione Biotechnologies, Artificial intelligence venture on VC4A

We’re solving the urgent need for fast, comprehensive, and accessible diagnostics in settings where disease evolves faster than existing tests can keep up. Current tools are slow, focused on one pathogen at a time, and disconnected leaving clinicians reactive and patients under-served.
Our solution is a fully integrated long-read sequencing device combined with an advanced machine learning engine that identifies pathogens, detects antimicrobial resistance, and recommends targeted therapies all in real time. By streaming data directly into our neural-network–powered analysis pipeline, we generate multiplexed, actionable reports in under an hour.
This end-to-end platform transforms raw DNA signals into precise diagnostics, AMR profiles, and treatment recommendations while also producing anonymized public-health data to support outbreak response and policy. It makes advanced biotech faster, smarter, and truly accessible where it’s needed most.

SectorsArtificial intelligence, Biotechnology and medical research, HealthTech, Medical equipment and supplies
LocationNairobi, Kenya
StageSign in to view details
MarketsSign in to view details
Customer modelSign in to view details
RevenueSign in to view details
ContactSign in to view details
Social media